Komori
Cyberdyne (7779) · FactAchieved

Debt reduction and capital strengthening through conversion of convertible bonds into shares

First written in FY2017-Q1. 1 of 3 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2017.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017-Q1AdvancedFY2017-Q2 – FY20172016: 220162017: 12017
Same theme, other companies

14 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 36 companies compared. The sentences above are computed from all 36.
Full recordFilings, disclosures and news, newest first
  1. FY2017AchievedAnnual report

    「Liabilities at the end of the current consolidated fiscal year decreased by ¥19,848.415 million from the end of the previous consolidated fiscal year to ¥622.120 million. This was primarily attributable to the conversion of the convertible bonds with stock acquisition rights into shares through the exercise of the attached rights.」

    The conversion of the convertible bonds with stock acquisition rights into shares was completed, reducing liabilities by ¥19,848.415 million to ¥622.120 million.
  2. FY2017-Q2AdvancedAnnual report

    「Total liabilities at the end of the current second quarter of the consolidated fiscal year decreased by ¥19,880.853 million from the end of the previous consolidated fiscal year to ¥589.682 million. This was primarily attributable to the conversion of the convertible bonds with stock acquisition rights into shares through the exercise of the attached rights.」

    The conversion of the convertible bonds with stock acquisition rights into shares reduced total liabilities by ¥19,880.853 million to ¥589.682 million, while total net assets increased to ¥46,495.690 million.
  3. FY2017-Q1First statedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Company converted bonds into shares through the exercise of rights attached to its 2017-maturity euro-yen convertible bonds with stock acquisition rights. As a result, capital stock and capital surplus each increased by ¥10,232.113 million, bringing them to ¥26,743.881 million and ¥26,679.881 million, respectively, at the end of the current first quarter of the consolidated fiscal year.」

    The exercise of rights attached to the convertible bonds with stock acquisition rights reduced liabilities and increased capital stock and capital surplus, resulting in a change in the capital structure.
Moved together

"Domestic and international clinical trials to expand the indications" moved the same way as this thread, in the same document, in 2 of its 3 moves.

2222★1234
  1. ★This thread
  2. 1Domestic and international clinical trials to expand the indications2×
  3. 2Early expansion and enhanced functionality of the product lineup2×
  4. 3Expansion of HAL product deployments and operations across applications2×
  5. 4Development of a next-generation multipurpose robotic production facility2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Cyberdyne yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.